Effectiveness and Safety of SGLT2 Inhibitor Treatment on Renal Outcomes in Patients with Type 2 Diabetes: A Nationwide Observational Cohort Study in South Korea

被引：0
|
作者：
Chang, Junhyuk [1 ]
Kim, Chungsoo [1 ]
Choi, Heejung [2 ]
Park, Rae Woong [1 ]
Lee, Sukhyang [3 ]
机构：
[1] Ajou Univ, Dept Biomed Sci, Grad Sch Med, Suwon, South Korea
[2] Ajou Univ, Dept Nephrol, Sch Med, Suwon, South Korea
[3] Ajou Univ, Div Clin Pharm, Coll Pharm, Suwon, South Korea
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1151
引用
收藏
页码：516 / 516
页数：1
相关论文
共 50 条
  • [1] Effectiveness and Safety of SGLT2 Inhibitors in Clinical Routine Treatment of Patients with Diabetes Mellitus Type 2
    Hopf, Maximilian
    Kloos, Christof
    Wolf, Gunter
    Mueller, Ulrich Alfons
    Mueller, Nicolle
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 8
  • [2] DAPAGLIFLOZIN, AN SGLT2 INHIBITOR FOR THE TREATMENT OF TYPE 2 DIABETES
    Demaris, K. M.
    White, J. R.
    DRUGS OF TODAY, 2013, 49 (05) : 289 - 301
  • [3] Efficacy and safety of SGLT2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes
    Nomiyama, Takashi
    Tanabe, Makito
    Murase, Kunitaka
    Motonaga, Ryoko
    Yanase, Toshihiko
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S93 - S93
  • [4] Safety and efficacy of the SGLT2 inhibitor dapagliflozin in older patients with type 2 diabetes
    Fioretto, P.
    de Bruin, T. W.
    Johnsson, E.
    Ptaszynska, A.
    Parikh, S.
    List, J. F.
    DIABETOLOGIA, 2013, 56 : S383 - S383
  • [5] Clinical Outcomes of Diabetic Ketoacidosis in Type 2 Diabetes Patients with and without SGLT2 Inhibitor Treatment: A Retrospective Study
    Nakhleh, Afif
    Othman, Areen
    Masri, Amin
    Zloczower, Moshe
    Zolotov, Sagit
    Shehadeh, Naim
    BIOMEDICINES, 2023, 11 (10)
  • [6] RENAL OUTCOMES OF SGLT2 INHIBITORS IN PATIENTS WITH DIABETES IN THE UNITED STATES: RETROSPECTIVE COHORT STUDY
    Abegaz, T.
    Ahmed, M. B.
    Ali, A. A.
    VALUE IN HEALTH, 2023, 26 (06) : S42 - S42
  • [7] Ketonuria as an Indicator of Improvement of Renal Function in Patients with Type 2 Diabetes Receiving SGLT2 Inhibitor Treatment
    Kim, Hyun Ah
    Jang, Han Na
    Kong, Sung Hye
    Lee, Young
    Choi, Sung Hee
    Cho, Young Min
    Jang, Hak Chul
    Oh, Tae Jung
    ENDOCRINOLOGY AND METABOLISM, 2024, 39 (04) : 653 - 658
  • [8] Canagliflozin, a Novel SGLT2 Inhibitor for Treatment of Type 2 Diabetes
    Nigro, Stefanie C.
    Riche, Daniel M.
    Pheng, Michelle
    Baker, William L.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (10) : 1301 - 1311
  • [9] The effect of SGLT2 inhibitor on clinical outcomes in patients with type 2 diabetes and atrial fibrillation
    Shin, S. H.
    Cho, Y.
    Park, M. A.
    Jang, J. H.
    Kim, D. Y.
    Kim, S. H.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [10] SGLT2 inhibition: efficacy and safety in type 2 diabetes treatment
    Scheen, Andre J.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (12) : 1879 - 1904
12345